Ligand (LGND): Net Sales Margin

Corporate emblem and logo of Ligand Pharmaceuticals Incorporated (LGND)

Ligand Pharmaceuticals (LGND) generates revenue through royalties from third-party manufacturers while minimizing headcount via automation. On GURU.Markets, the net profit margin reflects the current trend, where the value 20.30 indicates the actual figure. Efficiency is bolstered by developments in AI screening and nanotechnology, while the scalability of venture investments ensures profit growth without increasing operating expenses.

Ligand Corp (LGND) Net Return on Sales: for the period 07/04/2022 - 11/20/2026

Ligand Corp (LGND) - metric breakdowns and financial figures

- share price and expert price forecast:
- stock exchange capitalization data:
General company analysis:Ligand - LGND
Finished products of Ligand Pharma

This indicator measures the share of net income in total revenue, allowing investors to assess the efficiency of converting operating income into real capital during interim reporting periods. An analysis of net profit margins confirms the resilience of the partnership model of Ligand Pharmaceuticals (LGND) with pharma behemoths, demonstrating how effectively joint developments scale margins and validate the asset's fundamental value.

Who Ligand Pharmaceuticals competes with

HLN: Net Sales Margin|Net Return on Sales KVUE|Net Margin veronapharma.com|Net Return on Sales MENS (Jyong Biotech Corp)|Net Sales Margin AMRX|Company Sales Margin Perrigo Company plc|Net Sales Margin ALVO (Alvotech Biopharmaceuticals)|LQDA: Net Return on Sales|Galapagos N.V. - Net Sales Margin|ANIP - Net Sales Margin|MNKD: Net Sales Margin|amphastar.com (AMPH) - Net Sales Margin|PCRX (Pacira Pharmaceuticals) - Net Sales Margin|Return on Sales by Net Profit ARS Pharmaceuticals, Inc. (SPRY)|Net Sales Margin TBPH|AQST (Aquestive Therapeutics) - Net Profit Rate|scPharmaceuticals, Inc. - Return on Sales by Net Profit|Net Profit Rate TECX|tonixpharma.com - Net Sales Margin|Net Profit Rate SXTC (sxtchina.com)|Eupraxia Pharma (EPRX) - Net Margin|Return on Sales by Net Profit BioHarvest|Return on Sales by Net Profit EXOZ|Return on Sales by Net Profit Oramed Pharmaceuticals (ORMP)|Return on Sales by Net Profit ENTX (Entera Bio Corp)|MindWalk Holdings Inc. - Net Return on Sales|Net Sales Margin ABVC (ABVC BioPharma Inc)|CPIX - Return on Sales by Net Profit|Quantum BioPharma Corp - Net Sales Margin|FGEN (fibrogen.com) - Net Return on Sales|TELO (Telomir Pharmaceuticals) - Return on Sales by Net Profit|Rani Therapeutics Holdings - Net Profit Rate|Return on Sales by Net Profit SNYR|Net Margin rallybio.com RLYB|Net Sales Margin LEXX|PULM (Pulmatrix, Inc.) - Net Profit Rate|Pheton Holdings - Return on Sales by Net Profit|Net Sales Margin Aptorum Group Limited APM|LYRA: Return on Sales by Net Profit|IBO: Net Margin|TNFA: Net Sales Margin|YCBD: Company Net Profitability|Net Margin PainReform Ltd|CYTO (altamiratherapeutics.com) - Company Net Profitability|Net Sales Margin LIPO|OPTN - Net Margin|Net Margin pieris.com PIRS|Net Profit Rate PROC|PTPI - Net Margin|Qilian International Holding (QLI) - Return on Sales by Net Profit|SLRN: Net Sales Margin|Return on Sales by Net Profit TFF Pharma